Kevin Xu is the CEO of MEBO International, a California- and Beijing-based intellectual property management company specializing in applied health systems. He also leads Skingenix, which specializes in skin organ regeneration and the research and development of botanical drug products.

February 24, 2017 AT 11:29 AM | Kevin Xu, CEO, MEBO International
From reversing paralysis following a spinal cord injury to saving the lives of people who die waiting for an organ transplant, the need for increased research in tissue engineering and regeneration is imperative. Read more